CVRx, Inc. Common Stock
CVRX Real Time Price USDRecent trades of CVRX by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes in CVRX holdings by institutional investors
Quarterly net insider trading by CVRX's directors and management
* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.
- 1M
- 3M
- 6M
- YTD
- 1Y
- 2Y
- 5Y
- MAX
About
Key Metrics
Return (1d)
Return (30d)
Return (1Y)
CAGR (Total)
Max Drawdown
Beta
Alpha
Sharpe Ratio
Win Rate
Average Win
Average Loss
Annual Volatility
Annual Std Dev
Information Ratio
Treynor Ratio
Total Trades
Metrics Definitions
-
Alpha
Measures a portfolio's risk-adjusted performance against that of its benchmark
Learn More -
Annual Standard Deviation
Measures how much the portfolio's total return varies from its mean or average.
Learn More -
Annual Volatility
A statistical measure of the dispersion of returns for the portfolio.
Learn More -
Average Win
The average return (%) for trades that resulted in a positive return.
-
Average Loss
The average return (%) for trades that resulted in a negative return.
-
Beta
A measure of the volatility of the portfolio compared to the market as a whole.
Learn More -
CAGR
CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.
Learn More -
Information Ratio
A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.
Learn More -
Max Drawdown
the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.
Learn More -
Sharpe Ratio
The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.
Learn More -
Total Trades
The total number of trades made by this strategy.
-
Treynor Ratio
Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.
Learn More -
Win Rate
The percentage of total trades that resulted in a positive return.
Be the first to see our newest insights and key updates across all datasets.
Government lobbying spending instances
CVRX Estimated quarterly lobbying spending
CVRX Revenue by Segment or Geography
New CVRX patent grants
-
Patent Title: Antenna for use with medical device May. 21, 2024
-
Patent Title: Display screen or a portion thereof with graphical user interface Oct. 03, 2023
-
Patent Title: Display screen or a portion thereof with graphical user interface Oct. 03, 2023
-
Patent Title: Display screen or a portion thereof with graphical user interface Sep. 26, 2023
-
Patent Title: Display screen or a portion thereof with graphical user interface Sep. 26, 2023
-
Patent Title: Implant tool and improved electrode design for minimally invasive procedure Dec. 06, 2016
-
Patent Title: Hypertension treatment device and method for mitigating rapid changes in blood pressure Oct. 04, 2016
-
Patent Title: Electrode structures and methods for their use in cardiovascular reflex control Aug. 30, 2016
-
Patent Title: Method for monitoring physiological cycles of a patient to optimize patient therapy Aug. 16, 2016
-
Patent Title: Adapter for connection to pulse generator May. 24, 2016
-
Patent Title: Devices and methods for improved placement of implantable medical devices Dec. 01, 2015
-
Patent Title: Electrode structures and methods for their use in cardiovascular reflex control Jun. 02, 2015
-
Patent Title: Hypertension treatment device and method for mitigating rapid changes in blood pressure May. 05, 2015
-
Patent Title: System for setting programmable parameters for an implantable hypertension treatment device Mar. 10, 2015
-
Patent Title: Devices and methods for treatment of heart failure and associated conditions Feb. 03, 2015
-
Patent Title: Electrode structures and methods for their use in cardiovascular reflex control Nov. 04, 2014
-
Patent Title: Devices and methods for cardiovascular reflex treatments Sep. 16, 2014
-
Patent Title: Implant tool and improved electrode design for minimally invasive procedure Jul. 22, 2014
-
Patent Title: Devices and methods for electrode implantation Jun. 17, 2014
-
Patent Title: Devices and methods for treatment of heart failure and associated conditions Jun. 03, 2014
-
Patent Title: Electrode structures and methods for their use in cardiovascular reflex control May. 06, 2014
-
Patent Title: Baroreflex modulation using light-based stimulation May. 06, 2014
-
Patent Title: Automatic baroreflex modulation responsive to adverse event Apr. 29, 2014
-
Patent Title: System for setting programmable parameters for an implantable hypertension treatment device Apr. 29, 2014
-
Patent Title: Devices and methods for treatment of heart failure and associated conditions Apr. 15, 2014
-
Patent Title: Electrode array structures and methods of use for cardiovascular reflex control Dec. 31, 2013
-
Patent Title: System and method for sustained baroreflex stimulation Dec. 10, 2013
-
Patent Title: Devices and methods for treatment of heart failure and associated conditions Dec. 03, 2013
-
Patent Title: Baroreflex activation therapy with incrementally changing intensity Nov. 26, 2013
-
Patent Title: Devices and methods for cardiovascular reflex control Nov. 12, 2013
-
Patent Title: Measurement of patient physiological parameters Oct. 29, 2013
-
Patent Title: Devices and methods for electrode implantation Oct. 15, 2013
-
Patent Title: Measurement of patient physiological parameters Aug. 27, 2013
-
Patent Title: Baroreflex activation for pain control, sedation and sleep Jul. 02, 2013
-
Patent Title: Implant tool and improved electrode design for minimally invasive procedure May. 07, 2013
-
Patent Title: Devices and methods for treatment of heart failure and associated conditions Mar. 19, 2013
-
Patent Title: Devices and methods for treatment of heart failure and associated conditions Dec. 04, 2012
-
Patent Title: Devices and methods for treatment of heart failure and associated conditions Nov. 27, 2012
-
Patent Title: Method and apparatus for stimulation of baroreceptors in pulmonary artery Oct. 16, 2012
-
Patent Title: Devices and methods for treatment of heart failure and associated conditions Sep. 11, 2012
-
Patent Title: Devices, systems, and methods for improving left ventricular structure and function using baroreflex activation therapy Aug. 21, 2012
-
Patent Title: Baroreflex activation for sedation and sleep Jul. 17, 2012
-
Patent Title: Method for monitoring physiological cycles of a patient to optimize patient therapy Jul. 03, 2012
-
Patent Title: Methods and devices for controlling battery life in an implantable pulse generator Apr. 03, 2012
-
Patent Title: Measurement of patient physiological parameters Feb. 14, 2012
-
Patent Title: Devices and methods for cardiovascular reflex control Dec. 27, 2011
-
Patent Title: Baroreflex modulation to gradually decrease blood pressure Nov. 15, 2011
-
Patent Title: Connection structures for extra-vascular electrode lead body Sep. 06, 2011
-
Patent Title: Devices and methods for cardiovascular reflex control via coupled electrodes May. 24, 2011
-
Patent Title: Elective service indicator based on pulse count for implantable device Dec. 07, 2010
Federal grants, loans, and purchases
Estimated quarterly amount awarded to CVRX from public contracts
Recent insights relating to CVRX
Recent picks made for CVRX stock on CNBC
ETFs with the largest estimated holdings in CVRX
- ... Highest Price Target
- ... Median Price Target
- ... Lowest Price Target
|
Analyst
|
Firm
|
Current
|
Previous
|
Date
|
|---|
- Is $CVRX stock a Buy, Sell, or Hold?
- What is the price target for $CVRX stock?
* Analyst consensus is not financial advice. Please see our data disclaimers .
|
Shareholder
|
Shares Held
|
|---|
- Who owns $CVRX stock?
- Who owns the most shares of $CVRX stock?
- What funds own $CVRX stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view CVRX Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.
- Address Minneapolis, MN
- Market Cap 257.1 million
- Employees 206
- Industrial Classification Surgical & Medical Instruments & Apparatus